Mease, P., Gladman, D., Collier, D., Ritchlin, C., Helliwell, P., Coates, L., . . . Chung, J. (2019). A randomized, phase 3, double-blind trial examining methotrexate and etanercept as monotherapy or in combinstion for treating psoriatic arthritis: A comparison of the composite measures used to evaluate disease activity. BMJ Publishing Group.
Chicago Style (17th ed.) CitationMease, PJ, et al. A Randomized, Phase 3, Double-blind Trial Examining Methotrexate and Etanercept as Monotherapy or in Combinstion for Treating Psoriatic Arthritis: A Comparison of the Composite Measures Used to Evaluate Disease Activity. BMJ Publishing Group, 2019.
MLA引文Mease, PJ, et al. A Randomized, Phase 3, Double-blind Trial Examining Methotrexate and Etanercept as Monotherapy or in Combinstion for Treating Psoriatic Arthritis: A Comparison of the Composite Measures Used to Evaluate Disease Activity. BMJ Publishing Group, 2019.